Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Temporal aspects of visual perception in demyelinative diseases.
Exploratory validation of a multidimensional power wheelchair outcomes toolkit.
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
MCAM(+) CD8 T lymphocytes mediate CNS inflammation.
MS as a gateway disease.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
A new model for primary-progressive multiple sclerosis?
Fatigue Management in Multiple Sclerosis.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.
[Progressive multifocal leukoencephalopathy (review)].
Temperature dependence of water diffusion pools in brain white matter.
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Alemtuzumab for multiple sclerosis.

Pages